NO20075671L - Neurodegenerative markorer for psykiatriske tilstander - Google Patents

Neurodegenerative markorer for psykiatriske tilstander

Info

Publication number
NO20075671L
NO20075671L NO20075671A NO20075671A NO20075671L NO 20075671 L NO20075671 L NO 20075671L NO 20075671 A NO20075671 A NO 20075671A NO 20075671 A NO20075671 A NO 20075671A NO 20075671 L NO20075671 L NO 20075671L
Authority
NO
Norway
Prior art keywords
psychiatric conditions
markers
neurodegenerative
disease
values
Prior art date
Application number
NO20075671A
Other languages
English (en)
Norwegian (no)
Inventor
Aye Mu Myint
Manfred Schawaller
Robert Verkerk
Markus J Schwarz
Harald Hampel
Norbert Mueller
Original Assignee
Klinik Und Poliklinik Fuer Psy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinik Und Poliklinik Fuer Psy filed Critical Klinik Und Poliklinik Fuer Psy
Publication of NO20075671L publication Critical patent/NO20075671L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
NO20075671A 2005-04-06 2007-11-06 Neurodegenerative markorer for psykiatriske tilstander NO20075671L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
PCT/EP2006/002907 WO2006105907A1 (fr) 2005-04-06 2006-03-30 Marqueurs neurodégénératifs pour conditions psychiatriques

Publications (1)

Publication Number Publication Date
NO20075671L true NO20075671L (no) 2007-11-06

Family

ID=36293430

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20075671A NO20075671L (no) 2005-04-06 2007-11-06 Neurodegenerative markorer for psykiatriske tilstander
NO20120452A NO20120452L (no) 2005-04-06 2012-04-18 Neurodegenerative markorer for psykiatriske tilstander

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20120452A NO20120452L (no) 2005-04-06 2012-04-18 Neurodegenerative markorer for psykiatriske tilstander

Country Status (13)

Country Link
US (2) US20080131921A1 (fr)
EP (2) EP2146209B1 (fr)
JP (1) JP4958893B2 (fr)
AT (2) ATE468537T1 (fr)
CY (1) CY1110116T1 (fr)
DE (1) DE602006014379D1 (fr)
DK (2) DK1866650T3 (fr)
ES (2) ES2377704T3 (fr)
NO (2) NO20075671L (fr)
PL (2) PL2146209T3 (fr)
PT (2) PT1866650E (fr)
SI (1) SI1866650T1 (fr)
WO (1) WO2006105907A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008016101A1 (fr) * 2006-08-04 2008-02-07 Ajinomoto Co., Inc. Procédé d'évaluation de stress, appareil d'évaluation de stress, système d'évaluation de stress, programme d'évaluation de stress et support d'enregistrement associé
AT9843U1 (de) * 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
JP5410997B2 (ja) * 2008-01-31 2014-02-05 則行 川村 うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (fr) * 2008-02-05 2009-08-13 University Of Miami Elavl4 en tant que prédicteur d’une dépression chez des patients atteints de la maladie d'alzheimer et de la maladie de parkinson
DK2466312T3 (da) 2009-08-12 2020-01-13 Human Metabolome Tech Inc Phosphoethanolamine som biomarkør for depression
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP2596132A4 (fr) 2010-07-23 2013-12-18 Harvard College Procédés de détection de signatures de maladies ou pathologies dans des liquides biologiques
CN106399458A (zh) 2011-11-10 2017-02-15 福满代谢组技术有限公司 乙醇胺磷酸酯的测定方法
MX2014015434A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion.
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
US20150285805A1 (en) 2012-11-05 2015-10-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
WO2014164362A1 (fr) 2013-03-09 2014-10-09 Harry Stylli Procédés de détection du cancer de la prostate
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP2799878A1 (fr) * 2013-05-03 2014-11-05 SALION GmbH Procédé in vitro pour la détection précoce d'une inflammation potentielle, en particulier associée à un rejet de greffon
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
WO2017185085A1 (fr) * 2016-04-22 2017-10-26 Board Of Regents Of The University Of Nebraska Biomarqueurs pour surveiller une transformation immunitaire
EP3413050A1 (fr) * 2017-06-08 2018-12-12 SALION GmbH Procédé in vitro pour la détermination de maladies neurodégénératives
WO2019067660A1 (fr) * 2017-09-27 2019-04-04 University of North Carolina Wilmington Outil de dépistage d'agents pathogènes dérivés de l'homme et d'eaux usées humaines
EP3770606A4 (fr) 2018-03-19 2021-12-29 FUJIFILM Wako Pure Chemical Corporation Procédé d'évaluation d'un trouble psychiatrique
JP6678982B2 (ja) * 2018-03-22 2020-04-15 株式会社 日本医療機器技研 生体吸収性ステント
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
JP7389139B2 (ja) * 2019-11-26 2023-11-29 京セラ株式会社 ストレス計測システムおよびストレス計測方法
JP2023549028A (ja) * 2020-10-06 2023-11-22 学校法人沖縄科学技術大学院大学学園 アルツハイマー病（ａｄ）の診断のための指標を得るための方法
WO2024253194A1 (fr) * 2023-06-08 2024-12-12 東洋紡株式会社 Procédé d'aide à la stratification du niveau de fonction cérébrale, dispositif de stratification et programme de stratification
CN118566488B (zh) * 2024-04-10 2026-02-27 合肥歆智医疗器械有限公司 抑郁症检测用试剂组合、制造方法、检测系统及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (fr) * 1999-05-03 2000-11-08 Evotec BioSystems AG Méthodes de diagnostic ou de traitement de maladies neuropsychiatriques basées sur des taux accrus de la neurotrophine 3 dans la fluide cérébrospinale
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
US20120196300A1 (en) 2012-08-02
SI1866650T1 (sl) 2010-12-31
JP2008537111A (ja) 2008-09-11
DE602006014379D1 (de) 2010-07-01
HK1137219A1 (en) 2010-07-23
PL1866650T3 (pl) 2011-04-29
ES2346467T3 (es) 2010-10-15
EP2146209B1 (fr) 2011-11-16
JP4958893B2 (ja) 2012-06-20
DK2146209T3 (da) 2012-02-13
ATE534038T1 (de) 2011-12-15
EP1866650B1 (fr) 2010-05-19
PL2146209T3 (pl) 2012-05-31
PT1866650E (pt) 2010-06-01
ATE468537T1 (de) 2010-06-15
CY1110116T1 (el) 2015-01-14
EP2146209A1 (fr) 2010-01-20
ES2377704T3 (es) 2012-03-30
WO2006105907A1 (fr) 2006-10-12
PT2146209E (pt) 2011-12-30
NO20120452L (no) 2007-11-06
US20080131921A1 (en) 2008-06-05
EP1866650A1 (fr) 2007-12-19
DK1866650T3 (da) 2010-09-06

Similar Documents

Publication Publication Date Title
NO20075671L (no) Neurodegenerative markorer for psykiatriske tilstander
WO2006134390A3 (fr) Methode destinee a diagnostiquer une maladie neurodegenerative
PL1945622T3 (pl) Izotopowo znaczone związki benzofuranu jako środki obrazujące białka amyloidogenne
WO2005047484A3 (fr) Biomarqueurs pour la maladie d'alzheimer biomarkers for alzheimer's disease
EP1956962A4 (fr) Procede de determination de la forme d'un instrument pliable
EP1872705A4 (fr) Dispositif de detection de la forme d'un endoscope
EP1700096A4 (fr) Detection de proteines et de prions alteres de maniere conformationnelle
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
ATE495167T1 (de) Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors
FR2874675B1 (fr) Frein pour roue avec capteur d'usure
DE602004006664D1 (de) Vorrichtung zum Feststellen der Verschlechterung eines Sauerstoffkonzentrationsensors
DK1330656T3 (da) Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf
EP1860120A4 (fr) Procédé permettant d'améliorer un anticorps
WO2005124356A3 (fr) Utilisation d'une proteine cbp2 en tant que marqueur pour un cancer colorectal
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
EP1856526A4 (fr) Protéine d'interaction avec la thiorédoxine (txnip) en tant que régulateur de la fonction vasculaire
UA93870C2 (ru) Меченные радиоактивным галогеном производные фенилоксианилина
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
NO20030216D0 (no) Fremgangsmåte for å detektere patogene prionproteiner ved hjelp av massespektroskopi
DK1747465T3 (da) Anvendelse af hidtil ukendte biomarkører til detektion af testikelcarcinom in situ og afledte cancere i humane prøver
WO2005116659A3 (fr) Compositions et methodes associees a la maladie d'alzheimer
ATE408827T1 (de) Quantifizierung von stressbelastung
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
ATE442084T1 (de) Messung des energieverbrauchs
EP1907838A4 (fr) Fragment de vgf proteique neurosecretoire utilise comme biomarqueur pour la maladie d'alzheimer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application